Rubraca and Atorvastatin calcium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rubraca (rucaparib camsylate) and Atorvastatin calcium (atorvastatin calcium). Common drug interactions include nausea among females and haematocrit decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Rubraca and Atorvastatin calcium. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.
What is Rubraca?
Rubraca has active ingredients of rucaparib camsylate. eHealthMe is studying from 10,770 Rubraca users. Check the latest studies of Rubraca.
What is Atorvastatin calcium?
Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,310 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.
50 people who take Rubraca and Atorvastatin calcium together, and have interactions are studied.
What are the common drug interactions of Rubraca and Atorvastatin Calcium, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Fatigue (feeling of tiredness)
- Decreased appetite
- Weight decreased
- Constipation
- Dyspnoea (difficult or laboured respiration)
- Abdominal pain upper
- Hot flush (sudden feelings of heat)
- White blood cell count decreased
- Abdominal distension
male:
- Haematocrit decreased
- Haemoglobin decreased
- Dizziness
- Dyspepsia (indigestion)
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Hot flush (sudden feelings of heat)
- Muscle spasms (muscle contraction)
- Nausea (feeling of having an urge to vomit)
- Somnolence (a state of near-sleep, a strong desire for sleep)
What are the common drug interactions of Rubraca and Atorvastatin Calcium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Vitamin d decreased
50-59:
- Nausea (feeling of having an urge to vomit)
- Decreased appetite
- Constipation
- Dyspnoea (difficult or laboured respiration)
- Abdominal distension
- Burning sensation
- Flatulence (flatus expelled through the anus)
- Generalised oedema (swelling all over the body)
- Hepatic enzyme increased
- Hypoaesthesia (reduced sense of touch or sensation)
60+:
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Rash
- Blood urine present
- Hot flush (sudden feelings of heat)
- Tumour marker increased
- Haematocrit decreased
- Haemoglobin decreased
- Sunburn
- Dyspnoea (difficult or laboured respiration)
What are the existing conditions these people have? *
- Ovarian Cancer (cancer of ovary): 37 people, 74.00%
- Prostate Cancer: 5 people, 10.00%
- Fallopian Tube Cancer (cancer of fallopian tube): 4 people, 8.00%
- Neoplasm Malignant (cancer tumour): 3 people, 6.00%
- Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 3 people, 6.00%
- Endometrial Cancer: 3 people, 6.00%
* Approximation only. Some reports may have incomplete information.
Do you take Rubraca and Atorvastatin calcium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rubraca (10,770 reports)
- Atorvastatin calcium (77,310 reports)
Browse all drug interactions of Rubraca and Atorvastatin calcium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rubraca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Atorvastatin calcium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rubraca and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atorvastatin calcium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on rucaparib camsylate and atorvastatin calcium (the active ingredients of Rubraca and Atorvastatin calcium, respectively), and Rubraca and Atorvastatin calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Detrol La and Voltaren - now
- Dizziness in Pantoprazole, how severe and when it was recovered? - 2 seconds ago
- Could Morphine Sulfate cause Neonatal Disorder? - 5 seconds ago
- Drug interactions of Kisqali and Arsenic Trioxide - 7 seconds ago
- Blood Pressure Systolic Increased and Abdominal Pain - 8 seconds ago
- Could Orencia cause Traumatic Fracture? - 10 seconds ago
- Invega Sustenna and Pain Exacerbated for Men aged 40-49 - 19 seconds ago
- Norvasc and Clozapine drug interactions for women aged 60+ - 24 seconds ago
- Alcoholism and Oxygen Saturation Decreased - 25 seconds ago
- Vyvanse vs. Metadate Er, side effect and effectiveness comparison - 44 seconds ago